Sweet's syndrome associated with the intake of a selective cyclooxygenase-2 (COX-2) inhibitor

Cutaneous and Ocular Toxicology

Volumn 30, Issue 4, 2011, Pages 298-301

  Rosmaninho, Aristteles ^a   Lobo, Ins ^a   Selores, Manuela ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Celecoxib; Drug reaction; Neutrophilic dermatosis

Indexed keywords

C REACTIVE PROTEIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; PREDNISONE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ANAMNESIS; ARTICLE; BACKACHE; BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; HUMAN TISSUE; LEUKOCYTE; NEUTROPHILIA; PROTEIN BLOOD LEVEL;

BIOPSY; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; PREDNISONE; PYRAZOLES; SULFONAMIDES; SWEET SYNDROME; TREATMENT OUTCOME;

EID: 80455129689     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.579929     Document Type: Article

References (23)

1. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-356.
2. Cohen RP. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007;2:34.
3. Fett DL, Gibson LE, Su WP. Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995;70:234-240.
4. Kibbi AG, Zaynoun ST, Kurban AK, Najjar SS. Acute febrile neutrophilic dermatosis (Sweet's syndrome): case report and review of the literature. Pediatr Dermatol 1985;3:40-44. (Pubitemid 16179886)
5. Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993;11:149-157. (Pubitemid 23191681)
6. Su WPD, Liu HNH. Diagnostic criteria for Sweet's syndrome. Cutis 1986;37:167-174.
7. Arbetter KR, Hubbard KW, Markovic SN, Gibson LE, Phyliky RL. Case of granulocyte colony-stimulating factor-induced Sweet's syndrome. Am J Hematol 1999;61:126-129. (Pubitemid 29252390)
8. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:535-56; quiz 557.
9. Hommel L, Harms M, Saurat JH. The incidence of Sweet's syndrome in Geneva. A retrospective study of 29 cases. Dermatology (Basel) 1993;187:303-305. (Pubitemid 23333950)
10. Fitzgerald RL, McBurney EI, Nesbitt LT Jr. Sweet's syndrome. Int J Dermatol 1996;35:9-15. (Pubitemid 26034116)
11. Rosmaninho A, Machado S, Amorim I, Lobo I, Selores M. Henna tattoo and Sweet's syndrome: a possible relation. Eur J Dermatol 2009;19:642-643.
12. Cohen PR. Sweet's syndrome. Orphanet Encyclopedia 2003 http://www.orpha.net/data/patho/GB/uk-Sweet.pdf. Accessed on 25 July 2007.
13. Thibault MJ, Billick RC, Srolovitz H. Minocycline-induced Sweet's syndrome. J Am Acad Dermatol 1992;27:801-804.
14. Tefany FJ, Georgouras K. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive. Australas J Dermatol 1991;32:55-59.
15. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazoleassociated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996;34:918-923. (Pubitemid 26143882)
16. Fye KH, Crowley E, Berger TG, LeBoit PE, Connolly MK. Celecoxibinduced Sweet's syndrome. J Am Acad Dermatol 2001;45:300-302.
17. Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 2000;22:500-548. (Pubitemid 30434308)
18. Lewis JD, Kimmel SE, Localio AR, Metz DC, Farrar JT, Nessel L et al. Risk of serious upper gastrointestinal toxicity with overthe-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005;129:1865-1874. (Pubitemid 41772965)
19. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P et al.; Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-1080. (Pubitemid 40365348)
20. Grover SA, Coupal L, Zowall H. Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? Hypertension 2005;45:92-97. (Pubitemid 40066420)
21. Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 2003;64:1328-1334. (Pubitemid 37490238)
22. Helin-Salmivaara A, Huttunen T, Grönroos JM, Klaukka T, Huupponen R. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007;63:403-408. (Pubitemid 46399132)
23. Chung L, Chakravarty EF, Kearns P, Wang C, Bush TM. Bleeding complications in patients on celecoxib and warfarin. J Clin Pharm Ther 2005;30:471-477. (Pubitemid 41603022)